Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study.
Lancet Reg Health Eur
; 20: 100438, 2022 Sep.
Article
in En
| MEDLINE
| ID: mdl-36090671
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
/
Health_economic_evaluation
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Language:
En
Journal:
Lancet Reg Health Eur
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: